Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Related posts
-
‘She’s my inspiration’: Soon-to-be 100-year-old still woman walks over three miles a day at The Centre of Elgin
Soon-to-be 100-year-old Betty McKeown was celebrated during a party at The Centre of Elgin on Thursday.... -
Buffalo Grove DePaul student speaks out about antisemitic campus attack
A Stevenson High School graduate and DePaul University student spoke out about a campus antisemitic attack. -
Buffalo Grove DePaul student speaks out about antisemitic campus attack
A Stevenson High School graduate and DePaul University student spoke out about a campus antisemitic attack.